At 1 January 2004, 95% of the Group’s biological assets were in Sweden, however these were divested in March when the Group’s recently created forest holding company, Bergvik Skog AB, was divested to institutional investors. Stora Enso retained a minority shareholding of 43.3% and has signed longterm supply agreements with its new Associate at market rates. The divestment value of Bergvik Skog’s free standing trees was EUR 1 524.6 (SEK 13 753) million, other disposed fixed assets of EUR 89.9 (SEK 811) million representing the land under the trees, the roads thereon and sundry forestry equipment. Prior to the divestment in March, the change in the value of the Swedish biological assets had generated income of EUR 6.2 million, however after March, the Group’s 43.3% share of this income is aggregated with the normal trading result of Bergvik Skog and reported as an Associated Company result
(see Note 13).
In October 2004 Stora Enso divested its majority shareholding in PT Finnantara Intiga, its Borneo eucalyptus plantation company. The book value of the plantation at sale was EUR 21.8 million.
The accounting standard IAS 41, Agriculture, under which Stora Enso’s biological assets in the form of standing trees are fair market valued, came into effect on 1 January 2003. The value of Group forests thus increased from a previous book value of EUR 705.9 million to a fair value of EUR 1 561.7 million. The revaluation reserve amounted to EUR 855.8 million, which resulted in an increase in equity of EUR 615.4 million after the deduction of deferred tax; in accordance with IAS 8, this was credited directly to Retained Earnings as non-distributable equity, but has now been realised on the sale of the Swedish forests. The initial IAS 41 fair value adjustment on account of the Group’s forest associates added a further EUR 44.0 million to equity net of deferred tax.
Following the divestment of the Swedish forests in 2004, future biological income will not be material. Never-theless, periodic future changes resulting from growth, price and other factors will be entered in the Income Statement so that operating profit includes an adjustment for the change in value of the standing forest during the year. This change in value is made up of growth, harvesting and price fluctuations. The result for 2004 includes EUR 37.5 (EUR 116.2) million in respect of the change in fair value, being the growth and price effect, less EUR 30.4 (EUR 104.6) million for harvesting, resulting in the net gain of EUR 7.1 (EUR 11.6 million) shown in the Income Statement; all but EUR 0.9 million came from Bergvik Skog prior to its divestment.
At 31 December 2004 Stora Enso’s remaining biological assets had a fair value of EUR 64.6 (EUR 1 587.8) million and were located by value in Portugal (83%), Canada (3%) and China (14%). In addition, the Group now has three Associated Companies where IAS 41 is taken into account in computing their results:
• Bergvik Skog AB, the new 43.3% owned Swedish associate, had biological assets at a fair value of EUR 2 622.6 (SEK 23 657) million.
• Tornator Timberland Oy, a 41% owned associate which acquired the Group’s Finnish forest interests in 2002, had biological assets at a fair value of EUR 614.9 (EUR 628.9) million.
• Veracel, a 50% owned associate in Brazil, also has substantial forest plantations fair valued at EUR 70.0 (EUR 67.4) million, though with a growing cycle of only seven years.
Biological Assets
As at 31 December
EUR million
2003
2004
Assets reclassified from Fixed Assets '(see Note 11)